Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 24 points (-0.2%) at 15,303 as of Thursday, Sept. 12, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 960 issues advancing vs. 1,922 declining with 143 unchanged. The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 1.4%, DENTSPLY International ( XRAY), down 1.2%, Varian Medical Systems ( VAR), down 1.1%, Cooper Companies ( COO), down 1.1% and C.R. Bard ( BCR), down 0.8%. TheStreet would like to highlight 5 stocks pushing the industry lower today: 5. CareFusion ( CFN) is one of the companies pushing the Health Services industry lower today. As of noon trading, CareFusion is down $0.36 (-1.0%) to $37.02 on light volume. Thus far, 623,119 shares of CareFusion exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $37.00-$37.39 after having opened the day at $37.38 as compared to the previous trading day's close of $37.39. CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. CareFusion has a market cap of $8.0 billion and is part of the health care sector. Shares are up 29.9% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold. TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.